Pierre Thabet
Impact in
-
- Antibiotic Use and Resistance
-
- Meta-analysis and systematic reviews
Papers in
-
- Antibiotics Pharmacokinetics and Efficacy 3
-
- Meta-analysis and systematic reviews 3
- scientometrics and bibliometrics research 1
- Co-authors
- Salmaan Kanji (8 shared papers)Carole Lunny (6 shared papers)Dawid Pieper (4 shared papers)Anne Marie Whelan (1 shared paper)Claire L. O’Reilly (1 shared paper)Brian Hutton (3 shared papers)Andrea Murphy (1 shared paper)David M. Gardner (1 shared paper)
- Journals
- BMC Medical Research Methodology (1 paper)Systematic Reviews (1 paper)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (1 paper)Canadian Pharmacists Journal / Revue des Pharmaciens du Canada (1 paper)PLoS ONE (1 paper)
- Partner nations
- CanadaGermanyUnited Kingdom
In The Last Decade
Pierre Thabet
10 papers receiving 208 citations
Peers
Comparison fields: 5 of 81
- Applied Microbiology and Biotechnology 7
- Statistics, Probability and Uncertainty 23
- Research and Theory 2
- Health Informatics 2
- Chemical Health and Safety 1
Countries citing papers authored by Pierre Thabet
This map shows the geographic impact of Pierre Thabet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Thabet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Thabet more than expected).
Fields of papers citing papers by Pierre Thabet
This network shows the impact of papers produced by Pierre Thabet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Thabet. The network helps show where Pierre Thabet may publish in the future.
Co-authors
The 25 scholars most cited alongside Pierre Thabet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 128 | |
| 2 | 2017 | 25 | |
| 3 | 2021 | 21 | |
| 4 | 2022 | 12 | |
| 5 | 2016 | 10 | |
| 6 | 2024 | 9 | |
| 7 | 2022 | 6 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 1 | |
| 10 | 2022 | 1 | |
| 11 | 2025 | 0 |
About Pierre Thabet
Pierre Thabet is a scholar working on Pharmacology, Statistics, Probability and Uncertainty, Epidemiology, Pediatrics, Perinatology and Child Health and Sociology and Political Science, having authored 11 papers that have together received 214 indexed citations. Recurring topics across this work include Meta-analysis and systematic reviews (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Health Systems, Economic Evaluations, Quality of Life (1 paper), Pharmacological Effects and Toxicity Studies (1 paper), Epilepsy research and treatment (1 paper), Antibiotic Use and Resistance (1 paper), scientometrics and bibliometrics research (1 paper) and Cancer Immunotherapy and Biomarkers (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (7 citations), Statistics, Probability and Uncertainty (23 citations), Research and Theory (2 citations), Health Informatics (2 citations) and Chemical Health and Safety (1 citation). Pierre Thabet has collaborated with scholars based in Canada, Germany and United Kingdom. Frequent co-authors include Salmaan Kanji, Carole Lunny, Dawid Pieper, Anne Marie Whelan, Claire L. O’Reilly, Brian Hutton, Andrea Murphy, David M. Gardner, Adrienne Stevens and Erika MacDonald. Their work appears in journals such as BMC Medical Research Methodology, Systematic Reviews, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, Canadian Pharmacists Journal / Revue des Pharmaciens du Canada and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.